46 research outputs found

    Prevalence of JC Virus in Chinese Patients with Colorectal Cancer

    Get PDF
    BACKGROUND: JCV is a DNA polyomavirus very well adapted to humans. Although JCV DNA has been detected in colorectal cancers (CRC), the association between JCV and CRC remains controversial. In China, the presence of JCV infection in CRC patients has not been reported. Here, we investigated JCV infection and viral DNA load in Chinese CRC patients and to determine whether the JCV DNA in peripheral blood (PB) can be used as a diagnostic marker for JCV-related CRC. METHODOLOGY/PRINCIPAL FINDINGS: Tumor tissues, non-cancerous tumor-adjacent tissues and PB samples were collected from 137 CRC patients. In addition, 80 normal colorectal tissue samples from patients without CRC and PB samples from 100 healthy volunteers were also harvested as controls. JCV DNA was detected by nested PCR and glass slide-based dot blotting. Viral DNA load of positive samples were determined by quantitative real-time PCR. JCV DNA was detected in 40.9% (56/137) of CRC tissues at a viral load of 49.1 to 10.3×10(4) copies/µg DNA. Thirty-four (24.5%) non-cancerous colorectal tissues (192.9 to 4.4×10(3) copies/µg DNA) and 25 (18.2%) PB samples (81.3 to 4.9×10(3) copies/µg DNA) from CRC patients were positive for JCV. Tumor tissues had higher levels of JCV than non-cancerous tissues (P = 0.003) or PB samples (P<0.001). No correlation between the presence of JCV and demographic or medical characteristics was observed. The JCV prevalence in PB samples was significantly associated with the JCV status in tissue samples (P<0.001). Eleven (13.8%) normal colorectal tissues and seven (7.0%) PB samples from healthy donors were positive for JCV. CONCLUSIONS/SIGNIFICANCE: JCV infection is frequently present in colorectal tumor tissues of CRC patients. Although the association between JCV presence in PB samples and JCV status in tissue samples was identified in this study, whether PB JCV detection can serve as a marker for JCV status of CRC requires further study

    CAF-1 but not Rtt106 is involved in chromatin assembly after DSB repair.

    No full text
    <p><b>A</b>. Experimental system for measuring SSA. The galactose inducible HO endonuclease system induces one specific DSB in a defined location (red arrow) in order to analyze the DSB repair <i>in vivo</i> by PCR analysis with the indicated primer pairs. Repair of the HO lesion at the HO cleavage site (blue box) requires 5kb of resection back to the uncleavable HO cleavage site (red box). <b>B</b>. 10-fold serial dilution analysis of the indicated isogenic yeast strains WT (YMV045), <i>asf1</i>Δ (JKT200), <i>rad52</i>Δ (YMV046), <i>cac2</i>Δ (JLY078), and <i>cac2</i>Δ <i>rtt106</i>Δ (CCY020) to show the sensitivity to a single HO lesion. The WT data in the top panel are from the same petri dish as the other strains, but sections of the photograph were rearranged to obtain an optimal order of the strains for the figure. <b>C</b>. ChIP analysis of H3 levels flanking the DSB site (0.6kb) in WT (YMV045), <i>asf1</i>Δ (JKT200) and <i>cac2</i>Δ (JLY078) strains. The HO lesion was induced by adding galactose at 0hr. The H3 ChIP data were normalized to a control region on another chromosome (<i>SMC2</i>). All data are the average and standard deviation of three independent experiments.</p

    Delineation of the role of chromatin assembly and the Rtt101<sup>Mms1</sup> E3 ubiquitin ligase in DNA damage checkpoint recovery in budding yeast

    No full text
    <div><p>The DNA damage checkpoint is activated in response to DNA double-strand breaks (DSBs). We had previously shown that chromatin assembly mediated by the histone chaperone Asf1 triggers inactivation of the DNA damage checkpoint in yeast after DSB repair, also called checkpoint recovery. Here we show that chromatin assembly factor 1 (CAF-1) also contributes to chromatin reassembly after DSB repair, explaining its role in checkpoint recovery. Towards understanding how chromatin assembly promotes checkpoint recovery, we find persistent presence of the damage sensors Ddc1 and Ddc2 after DSB repair in <i>asf1</i> mutants. The genes encoding the E3 ubiquitin ligase complex Rtt101<sup>Mms1</sup> are epistatic to <i>ASF1</i> for survival following induction of a DSB, and Rtt101<sup>Mms1</sup> are required for checkpoint recovery after DSB repair but not for chromatin assembly. By contrast, the Mms22 substrate adaptor that is degraded by Rtt101<sup>Mms1</sup> is required for DSB repair <i>per se</i>. Deletion of <i>MMS22</i> blocks loading of Rad51 at the DSB, while deletion of <i>ASF1</i> or <i>RTT101</i> leads to persistent Rad51 loading. We propose that checkpoint recovery is promoted by Rtt101<sup>Mms1</sup>-mediated ubiquitylation of Mms22 in order to halt Mms22-dependent loading of Rad51 onto double-stranded DNA after DSB repair, in concert with the chromatin assembly-mediated displacement of Rad51 and checkpoint sensors from the site of repair.</p></div

    Rtt101<sup>Mms1</sup> ubiquitin ligase functions in the same pathway as Asf1 in response to a DSB.

    No full text
    <p><b>A and B</b>. 10-fold serial dilution analysis of WT (YMV045), <i>asf1</i>Δ (JKT200), <i>rad52</i>Δ (YMV046), <i>rtt101</i>Δ (CCY019), <i>mms1</i>Δ (CCY018), <i>mms22</i>Δ (CCY024), <i>rtt107</i>Δ (CCY022), <i>asf1</i>Δ <i>rtt101</i>Δ (CCY026), and <i>asf1</i>Δ <i>mms1</i>Δ (CCY027) strains containing the SSA HO repair system was performed as described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0180556#pone.0180556.g001" target="_blank">Fig 1B</a>. <b>C</b>. The HO endonuclease was induced by addition of galactose at 0hr in the WT (YMV045), <i>rtt101</i>Δ (CCY019), and <i>mms1</i>Δ (CCY018) strains. The top panels show an analysis of the cutting and repair. The lower panels show immunoblotting for the checkpoint kinase Rad53 from the same time course as the repair analysis, using a pan Rad53 antisera. The panels at the bottom show immunoblotting for phosphorylated Rad53 only. <b>D</b>. Calculation of colony formation from single unbudded cells following the indicated length of times of growth on galactose-containing plates in WT (YMV045), <i>rtt101</i>Δ (CCY019), <i>mms1</i>Δ (CCY018) and <i>asf1</i>Δ (JKT200) strains. Error bars represent standard deviation calculated from three independent experiments. <b>E</b>. Analysis of DNA levels (input) and H3 levels flanking the HO lesion using the identical strains shown in <b>D</b>. The left panel shows the input, and the right panel shows the ChIP analysis of H3. Both input and ChIP data were normalized as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0180556#pone.0180556.g001" target="_blank">Fig 1C</a>. All data are the average and standard deviation of three independent experiments.</p

    Blocking chromatin assembly leads to persistent checkpoint sensor presence at the site of repair.

    No full text
    <p><b>A</b>. The top panels show the histone H3 K56Ac levels assessed by ChIP analysis adjacent to the DSB site (0.6Kb) and at a control region <i>SMC2</i> in a wild type strain (YMV045). The H3 K56Ac ChIP data were normalized to H3 levels and to the input. All data are the average and standard deviation of three independent experiments. Asterisk (*) indicates significant changes compared to time 0 (p<0.05), as determined by the Student’s t-test. The lower panels show immunoblotting for the checkpoint kinase Rad53, where activation of the checkpoint leads to phosphorylation of Rad53 (Rad53-P) apparent as a slower migrating species. Tubulin serves as a loading control. Right panels (+Nicotinamide) are as in left panels, but in the presence of 25 mM nicotinamide. <b>B</b>. Analysis of proportion of cells with Ddc1-RFP in repair foci or <b>C</b>. Ddc2-GFP in repair foci at the indicated times following addition of galactose. Over 100 cells were examined at each time point. The data shown are from one experiment and are representative of the typical results.</p

    Mms22 promotes DSB repair via loading of Rad51.

    No full text
    <p><b>A</b>. Analysis of stability of Mms22-HA at the indicated times after shutting off transcription of pGAL1-Mms22HA by addition of glucose to cultures previously grown in YEPG. Strains used are wild type pGAL1-Mms22HA (LWY016), <i>asf1</i>Δ (CFY039) and <i>rtt101</i>Δ (CFY046). <b>B</b>. The HO endonuclease was induced by addition of galactose at 0hr in the WT (YMV045) and <i>mms22</i>Δ (CCY024) strains. The top panels show an analysis of the cutting and repair. The lower panels show immunoblotting for the checkpoint kinase Rad53 from the same time course as the repair analysis. <b>C</b>. ChIP analysis of Rad51 levels flanking the DSB site and a TELVIR control region in WT (YMV045) and <i>mms22</i>Δ (CCY024) strain. Data are normalized to the input. Data are the average and standard deviation of three independent experiments.</p

    Single Administration of Ultra-Low-Dose Lipopolysaccharide in Rat Early Pregnancy Induces TLR4 Activation in the Placenta Contributing to Preeclampsia

    No full text
    <div><p>Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant responses of immune system during pregnancy increase the risk of preeclampsia. Toll-like receptor 4 (TLR4) plays a crucial role in the activation of immune system at the maternal-fetal interface. This study aimed to generate a rat model of preeclampsia by lipopolysaccharide (LPS, a TLR4 agonist) administration on gestational day (GD) 5 as rats are subjected to placentation immediately after implantation between GDs 4 and 5, and to assess the contribution of TLR4 signaling to the development of preeclampsia. Single administration of 0.5 μg/kg LPS significantly increased blood pressure of pregnant rats since GD 6 (systolic blood pressure, 124.89 ± 1.79 mmHg <i>versus</i> 119.02 ± 1.80 mmHg, <i>P</i> < 0.05) and urinary protein level since GD 9 (2.02 ± 0.29 mg <i>versus</i> 1.11 ± 0.18 mg, <i>P</i> < 0.01), but barely affected blood pressure or proteinuria of virgin rats compared with those of saline-treated pregnant rats. This was accompanied with adverse pregnancy outcomes including fetal growth restriction. The expression of TLR4 and NF-κB p65 were both increased in the placenta but not the kidney from LPS-treated pregnant rats, with deficient trophoblast invasion and spiral artery remodeling. Furthermore, the levels of inflammatory cytokines were elevated systemically and locally in the placenta from pregnant rats treated with LPS. TLR4 signaling in the placenta was activated, to which that in the placenta of humans with preeclampsia changed similarly. In conclusion, LPS administration to pregnant rats in early pregnancy could elicit TLR4-mediated immune response at the maternal-fetal interface contributing to poor early placentation that may culminate in the preeclampsia-like syndrome.</p></div
    corecore